News
The German pharma will license a KRAS G12D inhibitor from Kumquat Biosciences. Elsewhere, a Biohaven OCD drug missed its ...
Germany’s Bayer and privately-held Kumquat Biosciences, a US biotech founded by pioneers of the KRAS pathway, have entered into an exclusive global license and collaboration to develop and ...
Today’s White House MAHA Commission report is expected to pull punches on pesticide regulation as Bayer lobbies to limit ...
From a new frontman at Old Trafford to a potential goalkeeping merry-go-round and a big Liverpudlian exit, here are 10 of the ...
Our weekly round-up of U.S. players' contributions across Europe begins with a look at how they fared in this weekend's ...
Bayer, the biotech company and manufacturer of Round Up, has substantially increased its spending on lobbying in Iowa since ...
It’s 2-0 at Stamford Bridge in Chelsea’s game against Bayer Leverkusen, and it’s Joao Pedro who has scored the second.It came ...
Bayer’s Roundup pesticide is linked with cancer. Its fight to dodge accountability threatens to leave sick people holding the ...
“Some of the northern rootworms have created an extended diapause life cycle, so they are able to stay underground for an extra year,” Hein said. “That combats our soybean-corn rotation, so then we ...
4don MSN
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results